SPL-B

Catalog No. A16085

SPL-B是转化酸性卷曲螺旋蛋白(TACC3)的口服活性抑制剂,可选择性抑制卵巢癌细胞中中心体微管的成核,而不会影响正常细胞中的纺锤体组装。
Catalog Num A16085
M. Wt 454.48
Formula C27H22N2O5
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 1465248-60-5
Synonyms Spindlactone B
SMILES CCN(CC1=CC=NC=C1)CC2=C(C=CC3=C2OC(=O)C=C3C4=CC5=CC=CC=C5OC4=O)O
SPL-B是转化酸性卷曲螺旋蛋白(TACC3)的口服活性抑制剂,可选择性抑制卵巢癌细胞中中心体微管的成核,而不会影响正常细胞中的纺锤体组装。
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 22 mL 110.02 mL 220.03 mL
0.5 mM 4.4 mL 22 mL 44.01 mL
1 mM 2.2 mL 11 mL 22 mL
5 mM 0.44 mL 2.2 mL 4.4 mL

*The above data is based on the productmolecular weight 454.48. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.